The Deadly Business of an Unregulated Global Stem Cell Industry
Access status:
Open Access
Metadata
Show full item recordType
ArticleAbstract
In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. In this report, we argue that Mrs Drysdale's death was avoidable, and it was the result of a pernicious global problem of an industry exploiting regulatory systems to sell unproven and unjustified interventions with stem cells.In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. In this report, we argue that Mrs Drysdale's death was avoidable, and it was the result of a pernicious global problem of an industry exploiting regulatory systems to sell unproven and unjustified interventions with stem cells.
See less
See less
Date
2017-03-29Publisher
BMJ Publishing GroupCitation
Lysaght, T., Lipworth, W., Hendl, T., Kerridge I., Munsie, M., Waldby, C.,Stewart, C., The Deadly Business of an Unregulated Global Stem Cell Industry, Journal of Medical Ethics, Published online 29 March 2017. doi: 10.1136/medethics-2016-104046Share